Skip to main content
. 1999 Apr 15;19(8):3094–3106. doi: 10.1523/JNEUROSCI.19-08-03094.1999

Table 1.

Clinical details of the 27 patients

Case Sex Age (years) Ethiology Eyesight Paresis Aphasia Lesion–test interval (months)
AK F 27 Stroke + + 12
AS M 49 Bleeding and trauma Myopic 43
HR M 54 Stroke Presbyopic + + 25
GZ M 58 Stroke Hyperopic + 2.5
RM M 42 Stroke Myopic 12.5
MS F 25 Tumor, encephalitis Hyperopic 192
MM F 43 Stroke Hyperopic + 3
RF M 43 Stroke + + 3
WD M 61 Stroke Presbyopic + 209
MH M 25 Tumor Myopic 53
SL F 45 Stroke 4
KH M 24 Hematoma + 14
KB M 55 Tumor Myopic 29
GK M 56 Stroke + + 116
AH F 45 Tumor 5
DW F 41 Stroke Left eye deficit + + 20
IH F 34 Stroke Myopic + 47
MK F 62 Ischemia Myopic 1.5
EL M 72 Stroke Presbyopic + + 2
UH M 25 Stroke 3
RB F 43 Tumor Myopic 16
HP M 52 Stroke 2
EP F 40 Stroke Hyperopic + 113
LG M 36 Stroke 55
GR F 59 Stroke 108
ML M 36 Stroke 4
IL F 62 Stroke Myopic + + 84

Included are gender, age, ethology of the lesion, visual acuity in both eyes, the presence of paresis or aphasia (indicated by a +), and the interval between the lesion and the testing.